Skip to main content
Log in

In-Depth Comparative Characterization of Hemoglobin Glycation in Normal and Diabetic Bloods by LC-MSMS

  • Research Article
  • Published:
Journal of The American Society for Mass Spectrometry

Abstract

The glycation level at β-Val-1 of the hemoglobin β chain in human blood (HbA1c%) is used to diagnose diabetes and other diseases. However, hemoglobin glycation occurs on multiple sites on different isoforms with different kinetics, but its differential profile has not been clearly demonstrated. In this study, hemoglobin was extracted from the blood of normal and diabetic individuals by protein precipitation. Triplicate solutions prepared from each sample were directly analyzed or digested with multiple enzymes and then analyzed by nano-LC/MS via bottom-up approach for side-by-side characterization. Intact hemoglobin analysis indicated a single glucose-dominant glycation, which showed good correlation with the HbA1c% values. Moreover, full sequence (100 %) of α/β globin was mapped and seven glycation sites were unambiguously assigned. In addition to β-Val-1, two other major sites at α-Lys-61 and β-Lys-66, which contain the common sequence HGKK, and four minor sites (<1 %) on α-Val-1, β-Lys-132, α-Lys-127, and α-Lys-40 were identified. All sites were shown to exhibit similar patterns of site distribution despite different glucose levels. Both the intact mass measurement and bottom-up data consistently indicated that the total glycation percentage of the β-globin was twice higher than the α-globin. Using molecular modeling, the 3D structure of the consensus sequence (HGKK) was shown to contain a phosphate triangle cavity, which helps to catalyze the glycation reaction. For the first time, hemoglobin glycation in normal and diabetic bloods was comparatively characterized in-depth with 100 % sequence coverage. The results provide insight about the HbA1c parameter and help define the new and old markers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Miedema, K.: Laboratory tests in diagnosis and management of diabetes mellitus. Practical considerations. Clin. Chem. Lab. Med. 41, 1259–1265 (2003)

    Article  CAS  Google Scholar 

  2. Gillery, P.: A history of Hba1c through clinical chemistry and laboratory medicine. Clin. Chem. Lab. Med. 51, 65–74 (2013)

    CAS  Google Scholar 

  3. Jeppsson, J.-O., Kobold, U., Barr, J., Finke, A., Hoelzel, W., Hoshino, T.: Approved IFCC reference method for the measurement of HbA1c in human blood. Clin. Chem. Lab. Med. 40, 78–89 (2002)

    Article  CAS  Google Scholar 

  4. Shapiro, R., McManus, M.J., Zalut, C., Bunn, H.F.: Sites of nonenzymatic glycosylation of human hemoglobin a. J. Biol. Chem. 255, 3120–3127 (1980)

    CAS  Google Scholar 

  5. Shaklai, N., Garlick, R.L., Bunn, H.F.: Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J. Biol. Chem. 259, 3812–3817 (1984)

    CAS  Google Scholar 

  6. Higgins, P.J., Bunn, H.F.: Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. J. Biol. Chem. 256, 5204–5208 (1981)

    CAS  Google Scholar 

  7. Selvin, E., Steffes, M.W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., Brancati, F.L.: Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N. Engl. J. Med. 362, 800–811 (2010)

    Article  CAS  Google Scholar 

  8. Sacks, D.B., Nathan, D.M., Lachin, J.M.: Gaps in the glycation gap hypothesis. Clin. Chem. 57, 150–152 (2011)

    Article  CAS  Google Scholar 

  9. Cohen, R.M., Smith, E.P.: Frequency of HbA1c discordance in estimating blood glucose control. Curr. Opin. Clin. Nutr. Metab. Care 11, 512–517 (2008)

    Article  CAS  Google Scholar 

  10. McCarter, R.J., Hempe, J.M., Gomez, R., Chalew, S.A.: Biological variation in Hba1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 27, 1259–1264 (2004)

    Article  CAS  Google Scholar 

  11. Jaisson, S., Gillery, P.: Evaluation of nonenzymatic posttranslational modification-derived products as biomarkers of molecular aging of proteins. Clin. Chem. 56, 1401–1412 (2010)

    Article  Google Scholar 

  12. Nacharaju, P., Acharya, A.S.: Amadori rearrangement potential of hemoglobin at its glycation sites is dependent on the three-dimensional structure of protein. Biochemistry 31, 12673–12679 (1992)

    Article  CAS  Google Scholar 

  13. Bai, X., Wang, Z., Huang, C., Wang, Z., Chi, L.: Investigation of non-enzymatic glycosylation of human serum albumin using ion trap-time of flight mass spectrometry. Molecules 17, 8782–8794 (2012)

    Article  CAS  Google Scholar 

  14. Peterson, K.P., Pavlovich, J.G., Goldstein, D., Little, R., England, J., Peterson, C.M.: What is hemoglobin a1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clin. Chem. 44, 1951–1958 (1998)

    CAS  Google Scholar 

  15. Xinyi, Z., Katalin, F.M., John, C., Phillip, D.: Characterization of glycated hemoglobin in diabetic patients: usefulness of electrospray mass spectrometry in monitoring the extent and distribution of glycation. J. Chromatogr. B 759, 1–15 (2001)

    Article  Google Scholar 

  16. Xie, H., Chakraborty, A., Ahn, J., Yu, Y.Q., Dakshinamoorthy, D.P., Gilar, M., Skilton, S.J., Mazzeo, J.R.: Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies. mAbs 2, 379–394 (2010)

    Google Scholar 

  17. Beck, A., Sanglier-Cianférani, S., Van, D.A.: Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry. Anal. Chem. 84, 4637–4646 (2012)

    Article  CAS  Google Scholar 

  18. Chen, S.L., Wu, S.L., Huang, L.J., Huang, J.B., Chen, S.H.: A global comparability approach for biosimilar monoclonal antibodies using LC–tandem MS based proteomics. J. Pharm. Biomed. Anal. 80, 126–135 (2013)

    Article  CAS  Google Scholar 

  19. Weykamp, C.W., Miedema, K., de Haan, T., Doelman, C.J.A.: Carbamylated hemoglobin interference in glycohemoglobin assays. Clin. Chem. 45, 438–440 (1999)

    CAS  Google Scholar 

  20. Prome, D., Blouquit, Y., Ponthus, C., Prome, J.C., Rosa, J.: Structure of the human adult hemoglobin minor fraction a1b by electrospray and secondary ion mass spectrometry. Pyruvic acid as amino-terminal blocking group. J. Biol. Chem. 266, 13050–13054 (1991)

    CAS  Google Scholar 

  21. Frolov, A., Hoffmann, P., Hoffmann, R.: Fragmentation behavior of glycated peptides derived from D-glucose, D-fructose, and D-ribose in tandem mass spectrometry. J. Mass Spectrom. 41, 1459–1469 (2006)

    Article  CAS  Google Scholar 

  22. Johansen, M.B., Kiemer, L., Brunak, S.: Analysis and prediction of mammalian protein glycation. Glycobiology 16, 844–853 (2006)

    Article  CAS  Google Scholar 

  23. Baynes, J.W., Watkins, N.G., Fisher, C.I., Hull, C.J., Patrick, J.S., Ahmed, M.U., Dunn, J.A., Thorpe, S.R.: The Amadori product on protein: structure and reactions. Prog. Clin. Biol. Res. 304, 43–67 (1989)

    CAS  Google Scholar 

  24. Shilton, B.H., Walton, D.J.: Sites of glycation of human and horse liver alcohol dehydrogenase in vivo. J. Biol. Chem. 266, 5587–5592 (1991)

    CAS  Google Scholar 

  25. Shilton, B.H., Campbell, R.L., Walton, D.J.: Site specificity of glycation of horse liver alcohol dehydrogenase in vitro. Eur. J. Biochem. 215, 567–572 (1993)

    Article  CAS  Google Scholar 

  26. Acosta, J., Hettinga, J., Flückiger, R., Krumrei, N., Goldfine, A., Angarita, L., Halperin, J.: Molecular basis for a link between complement and the vascular complications of diabetes. Proc. Natl. Acad. Sci. U. S. A. 97, 5450–5455 (2000)

    Article  CAS  Google Scholar 

  27. Shigenori, I., Takashi, N., Daisuke, Y.: Relationship between impaired glycation and the n-terminal structure of the hb görwihl [β5(a2)pro→ala] variant. Hemoglobin 34, 151–156 (2010)

    Article  CAS  Google Scholar 

  28. Ito, S., Nakahari, T., Yamamoto, D.: The structural feature surrounding glycated lysine residues in human hemoglobin. Biomed. Res. 32, 217–223 (2011)

    Article  CAS  Google Scholar 

Download references

Acknowledgment

The authors acknowledge support for this work by the National Science Council in Taiwan (NSC 102-2113-M-006-005-MY3).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shu-Hui Chen.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Table S1

(PDF 104 kb)

Figure S1

(TIFF 1538 kb)

High Resolution Image (JPEG 39 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, SH., Wang, TF., Wu, CH. et al. In-Depth Comparative Characterization of Hemoglobin Glycation in Normal and Diabetic Bloods by LC-MSMS. J. Am. Soc. Mass Spectrom. 25, 758–766 (2014). https://doi.org/10.1007/s13361-014-0830-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13361-014-0830-2

Key words

Navigation